Search

Deanna L. Pratt

Examiner (ID: 3454, Phone: (571)272-7649 , Office: P/2911 )

Most Active Art Unit
2911
Art Unit(s)
2931, 2911
Total Applications
2897
Issued Applications
2827
Pending Applications
10
Abandoned Applications
66

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5786393 [patent_doc_number] => 20060205634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease' [patent_app_type] => utility [patent_app_number] => 11/401206 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10487 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205634.pdf [firstpage_image] =>[orig_patent_app_number] => 11401206 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/401206
Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease Apr 9, 2006 Abandoned
Array ( [id] => 5663317 [patent_doc_number] => 20060253913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Production of hSA-linked butyrylcholinesterases in transgenic mammals' [patent_app_type] => utility [patent_app_number] => 11/401390 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 40621 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20060253913.pdf [firstpage_image] =>[orig_patent_app_number] => 11401390 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/401390
Production of hSA-linked butyrylcholinesterases in transgenic mammals Apr 9, 2006 Abandoned
Array ( [id] => 4822949 [patent_doc_number] => 20080227691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Blood Coagulation FVIII Analogues' [patent_app_type] => utility [patent_app_number] => 11/910349 [patent_app_country] => US [patent_app_date] => 2006-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13804 [patent_no_of_claims] => 547 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227691.pdf [firstpage_image] =>[orig_patent_app_number] => 11910349 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/910349
Blood Coagulation FVIII Analogues Apr 2, 2006 Abandoned
Array ( [id] => 602589 [patent_doc_number] => 07432352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Hybrid molecules having Factor VII/VIIa activity' [patent_app_type] => utility [patent_app_number] => 11/393327 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 1 [patent_no_of_words] => 17613 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432352.pdf [firstpage_image] =>[orig_patent_app_number] => 11393327 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/393327
Hybrid molecules having Factor VII/VIIa activity Mar 29, 2006 Issued
Array ( [id] => 5106960 [patent_doc_number] => 20070065838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'OLIGONUCLEOTIDE MEDIATED NUCLEIC ACID RECOMBINATION' [patent_app_type] => utility [patent_app_number] => 11/277337 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 22681 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20070065838.pdf [firstpage_image] =>[orig_patent_app_number] => 11277337 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/277337
OLIGONUCLEOTIDE MEDIATED NUCLEIC ACID RECOMBINATION Mar 22, 2006 Abandoned
Array ( [id] => 5625868 [patent_doc_number] => 20060264373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Modified vitamin K-dependent polypeptides' [patent_app_type] => utility [patent_app_number] => 11/377904 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24392 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264373.pdf [firstpage_image] =>[orig_patent_app_number] => 11377904 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377904
Modified vitamin K-dependent polypeptides Mar 15, 2006 Abandoned
Array ( [id] => 5626111 [patent_doc_number] => 20060264616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Modified vitamin K-dependent polypeptides' [patent_app_type] => utility [patent_app_number] => 11/377620 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21834 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264616.pdf [firstpage_image] =>[orig_patent_app_number] => 11377620 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377620
Modified vitamin K-dependent polypeptides Mar 15, 2006 Issued
Array ( [id] => 5337304 [patent_doc_number] => 20090053768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Novel Phospholipase C Enzyme (S)' [patent_app_type] => utility [patent_app_number] => 12/224867 [patent_app_country] => US [patent_app_date] => 2006-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12371 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053768.pdf [firstpage_image] =>[orig_patent_app_number] => 12224867 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/224867
Phospholipase C enzyme(s) Mar 9, 2006 Issued
Array ( [id] => 5859774 [patent_doc_number] => 20060229250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Ghrelin associated peptide and its uses' [patent_app_type] => utility [patent_app_number] => 11/372888 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13066 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20060229250.pdf [firstpage_image] =>[orig_patent_app_number] => 11372888 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/372888
Ghrelin associated peptide and its uses Mar 8, 2006 Abandoned
Array ( [id] => 5034636 [patent_doc_number] => 20070099175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Modified fluorescent proteins' [patent_app_type] => utility [patent_app_number] => 11/371240 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19981 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099175.pdf [firstpage_image] =>[orig_patent_app_number] => 11371240 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/371240
Modified fluorescent proteins Mar 8, 2006 Abandoned
Array ( [id] => 5834712 [patent_doc_number] => 20060246543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Slim compositions and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/368166 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 55090 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246543.pdf [firstpage_image] =>[orig_patent_app_number] => 11368166 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/368166
Slim compositions and methods of use thereof Mar 2, 2006 Abandoned
Array ( [id] => 4792107 [patent_doc_number] => 20080293081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Fluorescence Polarization Assays for Acetyltransferase/Deacetylase Activity' [patent_app_type] => utility [patent_app_number] => 11/885390 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19280 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293081.pdf [firstpage_image] =>[orig_patent_app_number] => 11885390 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/885390
Fluorescence Polarization Assays for Acetyltransferase/Deacetylase Activity Mar 2, 2006 Abandoned
Array ( [id] => 5785355 [patent_doc_number] => 20060205036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Coagulation Factor VII polypeptides' [patent_app_type] => utility [patent_app_number] => 11/367189 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 29305 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205036.pdf [firstpage_image] =>[orig_patent_app_number] => 11367189 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/367189
Coagulation Factor VII polypeptides Mar 2, 2006 Abandoned
Array ( [id] => 5753941 [patent_doc_number] => 20060223090 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Polynucleotides encoding human secreted proteins' [patent_app_type] => utility [patent_app_number] => 11/366980 [patent_app_country] => US [patent_app_date] => 2006-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 283049 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223090.pdf [firstpage_image] =>[orig_patent_app_number] => 11366980 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/366980
Polynucleotides encoding human secreted proteins Mar 2, 2006 Abandoned
Array ( [id] => 5028891 [patent_doc_number] => 20070270338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-22 [patent_title] => 'pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/365484 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14574 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20070270338.pdf [firstpage_image] =>[orig_patent_app_number] => 11365484 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/365484
pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof Feb 28, 2006 Issued
Array ( [id] => 5277954 [patent_doc_number] => 20090130086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'FXIII Variants with Improved Properties' [patent_app_type] => utility [patent_app_number] => 11/817039 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9993 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20090130086.pdf [firstpage_image] =>[orig_patent_app_number] => 11817039 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817039
FXIII Variants with Improved Properties Feb 26, 2006 Abandoned
Array ( [id] => 5580941 [patent_doc_number] => 20090176287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-09 [patent_title] => 'PRODUCING CAROTENOIDS' [patent_app_type] => utility [patent_app_number] => 11/817120 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 20138 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20090176287.pdf [firstpage_image] =>[orig_patent_app_number] => 11817120 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817120
PRODUCING CAROTENOIDS Feb 23, 2006 Abandoned
Array ( [id] => 8458045 [patent_doc_number] => 08293710 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Method for treating wounds using an EGF-like domain of thrombomodulin' [patent_app_type] => utility [patent_app_number] => 11/361560 [patent_app_country] => US [patent_app_date] => 2006-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 7116 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11361560 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/361560
Method for treating wounds using an EGF-like domain of thrombomodulin Feb 23, 2006 Issued
Array ( [id] => 5296527 [patent_doc_number] => 20090011453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Methods for Producing Proteins Using Hamster Igf-1' [patent_app_type] => utility [patent_app_number] => 11/884538 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11144 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011453.pdf [firstpage_image] =>[orig_patent_app_number] => 11884538 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884538
Nucleic acids encoding hamster 1GF-1 proteins and methods thereof Feb 20, 2006 Issued
Array ( [id] => 5303510 [patent_doc_number] => 20090298162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'BIOSENSORS FOR MONITORING RECEPTOR-MEDIATED G-PROTEIN ACTIVATION' [patent_app_type] => utility [patent_app_number] => 11/816517 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 52 [patent_figures_cnt] => 52 [patent_no_of_words] => 18398 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20090298162.pdf [firstpage_image] =>[orig_patent_app_number] => 11816517 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/816517
Biosensors for monitoring receptor-mediated G-protein activation Feb 15, 2006 Issued
Menu